We are proud to share that our CEO, Meredith Cummins, has been appointed President of the International Neuroendocrine Cancer Alliance (INCA).
Meredith has served on the INCA Board for two years and has been Chair of the Research Committee since 2024. In her new role, she will help lead a global network of patient organisations working to educate, support, and advocate for people living with neuroendocrine tumours (NETs).
Meredith says:
” It is a great honour to be the President of INCA. To be part of a truly global membership of organisations enables us to educate, support, and advocate for the NET community. The collaboration and collegiality of INCA members is inspiring, and I look forward to working with everyone in my appointment of President.”
For Australian patients, having Meredith in this role means our voice is stronger than ever in global discussions about NET care, research, and support. We congratulate Meredith and look forward to seeing the difference she will make for patients worldwide.
